These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22294342)

  • 1. Development of metastatic Crohn's disease of the skin while on anti-TNF biologics.
    Patel AV; Jones DM; Hill JC; MacDermott RP
    Inflamm Bowel Dis; 2012 Jun; 18(6):1188-90. PubMed ID: 22294342
    [No Abstract]   [Full Text] [Related]  

  • 2. Sarcoidosis during infliximab therapy for Crohn's disease.
    Takahashi H; Kaneta K; Honma M; Ishida-Yamamoto A; Ashida T; Kohgo Y; Ohsaki Y; Iizuka H
    J Dermatol; 2010 May; 37(5):471-4. PubMed ID: 20536653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrotic strictures and anti-TNF-alpha therapy in Crohn's disease.
    Sorrentino D; Terrosu G; Vadalà S; Avellini C
    Digestion; 2007; 75(1):22-4. PubMed ID: 17429204
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute coronary syndrome after infliximab therapy in a patient with Crohn's disease.
    Panteris V; Perdiou A; Tsirimpis V; Karamanolis DG
    World J Gastroenterol; 2006 Oct; 12(38):6235-8. PubMed ID: 17036404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab.
    Haennig A; Bonnet D; Thebault S; Alric L
    Gastroenterol Clin Biol; 2010 Sep; 34(8-9):e7-8. PubMed ID: 20189334
    [No Abstract]   [Full Text] [Related]  

  • 6. Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab.
    Mañosa M; Domènech E; Marín L; Olivé A; Zabana Y; Cabré E; Gassull MA
    Gut; 2008 Apr; 57(4):559; author reply 559-60. PubMed ID: 18334664
    [No Abstract]   [Full Text] [Related]  

  • 7. Adalimumab for cutaneous metastatic Crohn's disease.
    Cury DB; Moss AC; Elias G; Nakao A
    Inflamm Bowel Dis; 2010 May; 16(5):723-4. PubMed ID: 19728388
    [No Abstract]   [Full Text] [Related]  

  • 8. Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.
    Iborra M; Beltrán B; Bastida G; Aguas M; Nos P
    J Crohns Colitis; 2011 Apr; 5(2):157-61. PubMed ID: 21453886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatic fever in a patient receiving infliximab therapy for Crohn disease.
    Abu-El-Haija M; Stasheff S; Atkins DL; Bishop WP
    J Pediatr Gastroenterol Nutr; 2011 Mar; 52(3):360-1. PubMed ID: 21150656
    [No Abstract]   [Full Text] [Related]  

  • 11. Splenic tuberculosis in a patient with Crohn's disease on infliximab: case report.
    Cappello M; Randazzo C; Rizzuto G; Bonura C; Di Vita G; Galia M
    Inflamm Bowel Dis; 2010 Mar; 16(3):368-70. PubMed ID: 19591134
    [No Abstract]   [Full Text] [Related]  

  • 12. Case report of aseptic meningitis in a patient with Crohn's disease under infliximab therapy.
    Manthey C; Lohse AW; Pace A
    Inflamm Bowel Dis; 2011 Feb; 17(2):E10. PubMed ID: 20848497
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-TNFalpha therapy in a rare case of Crohn's disease: still a panacea.
    Verburg R; Zelissen P; Rothova A; Siersema PD; Oldenburg B
    Inflamm Bowel Dis; 2008 Oct; 14(10):1457-60. PubMed ID: 18383178
    [No Abstract]   [Full Text] [Related]  

  • 14. Patient outcomes after anti TNF-alpha drugs for Crohn's disease.
    Assasi N; Blackhouse G; Xie F; Marshall JK; Irvine EJ; Gaebel K; Robertson D; Campbell K; Hopkins R; Goeree R
    Expert Rev Pharmacoecon Outcomes Res; 2010 Apr; 10(2):163-75. PubMed ID: 20384563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rare case of pericarditis, complication of infliximab treatment for Crohn's disease.
    Devasahayam J; Pillai U; Lacasse A
    J Crohns Colitis; 2012 Jul; 6(6):730-1. PubMed ID: 22465046
    [No Abstract]   [Full Text] [Related]  

  • 16. Infliximab-associated psoriasis in children with Crohn's disease may require withdrawal of anti-tumor necrosis factor therapy.
    Broge T; Nguyen N; Sacks A; Davis M
    Inflamm Bowel Dis; 2013 Apr; 19(5):E75-7. PubMed ID: 23435403
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor necrosis factor α antagonist-associated psoriasis in inflammatory diseases: an analysis of the FDA adverse event reporting system.
    Kip KE; Swoger JM; Grandinetti LM; Barrie AM; Greer JB; Regueiro MD
    Inflamm Bowel Dis; 2013 May; 19(6):1164-72. PubMed ID: 23518804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctive histopathologic phenotype in resection specimens from patients with Crohn's disease receiving anti-TNF-α therapy.
    Schaeffer DF; Walsh JC; Kirsch R; Waterman M; Silverberg MS; Riddell RH
    Hum Pathol; 2014 Sep; 45(9):1928-35. PubMed ID: 25022570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphomatoid papulosis in a patient with Crohn's disease treated with infliximab.
    Outlaw W; Fleischer A; Bloomfeld R
    Inflamm Bowel Dis; 2009 Jul; 15(7):965-6. PubMed ID: 18798565
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of psoriasis induced by infliximab treatment for Crohn's disease].
    Jwa YJ; Kim NH; Park HJ; Park JS; Bae WK; Kim KA; Lee JS; Moon YS
    Korean J Gastroenterol; 2010 Nov; 56(5):324-8. PubMed ID: 21099241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.